Announcements

Showing items 5301 - 5310 of 6208 stories.

WVU grad student pursues drug to treat aggressive form of blood cancer

Multiple myeloma doesn’t play around. Within five years of being diagnosed with this form of blood cancer, about half of all patients die from it. And even if they initially respond well to treatment, the cancer can hide in their bone marrow for years before reemerging in a tougher-to-treat form.

Learn about becoming a Blue Zone University at WVU Town Hall

Learn how becoming the first certified Blue Zones University in the world can inspire healthy transformation, economic vitality and higher well-being. Join us for a university-wide Town Hall at the WVU Health Sciences Center on Thur., Nov. 8 at noon. If you can’t join us, you can watch the event live at https://www.hsc.wvu.edu/live-feed.

WVCTSI names 5 new Research Scholars 

MORGANTOWN, W.Va. – Five clinical and translational scientists have been named Research Scholars by the West Virginia Clinical and Translational Science Institute (WVCTSI). These five investigators from the West Virginia University (WVU) School of Medicine include: Amelia Adcock, M.D., Cassie Brode, Ph.D., Elizabeth Engler-Chiurazzi, Ph.D., James Mahoney III, Ph.D., and Rashi Mehta, M.D.

Protecting coal miners from black lung disease

In a report published by the National Academies of Sciences, Engineering and Medicine, WVU School of Public Health researcher Michael McCawley and his colleagues pinpoint shortcomings in how miners’ exposure to respirable coal-mine dust is monitored. Inhaling this dust over time leads to black lung disease.